Target intelligence / Profile preview

PRKCA antisense RNA 1 (PRKCA-AS1)

Target
PRKCA-AS1
Molecular classification
Other (antisense long non-coding RNA, lncRNA)
01

Overview

PRKCA antisense RNA 1 (PRKCA-AS1) is an antisense long non-coding RNA (lncRNA) gene located on human chromosome 17q24.2 that is transcribed antisense to the PRKCA (protein kinase C alpha) gene. PRKCA-AS1 is predominantly expressed in the nucleus and is implicated in the epigenetic regulation of its sense partner gene, PRKCA, by recruiting DNA methyltransferase 1 (DNMT1) to the promoter of PRKCA, thereby modifying DNA methylation and suppressing PRKCA transcription. Its expression and function are influenced by inflammatory signaling (e.g., p38/MAPK pathway), and altered levels of PRKCA-AS1 have been observed in disease contexts such as rheumatic heart disease and oral squamous cell carcinoma. Evidence suggests it may contribute to malignancy progression, likely by affecting cellular proliferation and gene silencing via epigenetic regulation. PRKCA-AS1 is not currently considered a direct therapeutic target such as a receptor, enzyme, or transporter, but it is a functional non-coding RNA with relevance in disease biology.

02

Biological functions

Regulation of gene expression (via epigenetic mechanisms)Modulation of DNA methylationInhibition of PRKCA transcription under inflammatory stimuli
03

Disease associations

Cancer (e.g., oral squamous cell carcinoma)Cardiovascular and inflammatory diseases (evidence from rheumatic heart disease, RHD)

Beyond the preview

Go deeper on PRKCA antisense RNA 1 (PRKCA-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRKCA antisense RNA 1 (PRKCA-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call